How GenAI is transforming the future of infusion therapy

Context & Objectives

A leading healthcare provider seeking to streamline patient intake and reduce administrative workload.

Manual patient intake processes created inefficiencies and operational bottlenecks:

• Time-Consuming: Staff spent excessive hours collecting and entering patient data.
• Error-Prone: Manual entry led to record inaccuracies and compliance risks.
• High Costs: Significant investment in clerical support to manage intake.
• Patient Frustration: Long intake times and redundant data requests lowered satisfaction.
• Limited Scalability: Growing patient volumes strained existing workflows.

Approach & Solution

The Virtual Infusion Guide (VIG) system will be developed iteratively, integrating AI, structured knowledge bases, and human expertise to maximize efficiency while ensuring quality and compliance. Key components include:

• Rx Analysis Automation: AI-powered extraction and validation of prescription details.
• Knowledge Base Development: Centralized repository linking drug and insurer-specific requirements.
• Conversational Assistance: AI chatbot for real-time Guide support.
• Feedback & Refinement: Continuous learning from human input to improve accuracy.
• Integration with LISA: Enhancements to the existing insurance interaction phone bot.
• Patient Insights Platform: Data-driven analytics for clinical and operational improvements.

Upon implementation, the VIG system is expected to:

• Automate complex workflows, reducing errors and processing time.
• Scale expert knowledge, enabling all Guides to benefit from real-time decision support.
• Provide data-driven insights to improve operational performance.
• Ensure a smooth transition from the LISA platform with long-term sustainability.

Results & Added Value

1. Increased number of prescriptions processed per VIG per day.
2. Support expansion without linear cost increases.
3. Strengthened competitive advantage by leveraging AI-powered decision support to enhance patient care.
4. Enabled data-driven collaborations with Pharma for research and development.
   

   Why Forte Group